Stay updated on GARNET: Anti-PD-1 Antibody Clinical Trial

Sign up to get notified when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GARNET: Anti-PD-1 Antibody Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new total of 130 study locations, with several principal investigators added, including Charles A. Leath, III and Michael S. Gordon. Additionally, several previously listed locations have been withdrawn, including sites in Phoenix, Atlanta, and Buenos Aires.
    Difference
    15%
    Check dated 2025-03-04T06:46:37.000Z thumbnail image
  5. Check
    78 days ago
    Change Detected
    Summary
    The website has updated its clinical trials information, adding new contact details and a revision to version 2.14.0, while removing the previous version 2.13.3 and its associated contact information.
    Difference
    45%
    Check dated 2025-01-08T16:02:33.000Z thumbnail image
  6. Check
    99 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-18T04:42:02.000Z thumbnail image
  7. Check
    106 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-12-10T23:45:13.000Z thumbnail image
  8. Check
    114 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing clearer information on who to contact and where the study is taking place, reflecting a revision from v2.12.2 to v2.13.0.
    Difference
    0.5%
    Check dated 2024-12-03T20:22:23.000Z thumbnail image
  9. Check
    121 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.12.2, with previous content related to the safety and efficacy of dostarlimab in various cancer studies removed.
    Difference
    4%
    Check dated 2024-11-26T16:00:02.000Z thumbnail image

Stay in the know with updates to GARNET: Anti-PD-1 Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GARNET: Anti-PD-1 Antibody Clinical Trial page.